{"DataElement":{"publicId":"4383231","version":"1","preferredName":"PI-RADS T2 Peripheral Zone Assessed Score","preferredDefinition":"Score to represent a structured reporting scheme for multiparametric prostate cancer imaging including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS).","longName":"PIRADS_T2_PZ_SC","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"4382375","version":"1","preferredName":"PI-RADS T2 Peripheral Zone (PZ) Assessed","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._The time it takes for the net nuclear spin in the plane that is perpendicular to the magnetic field of a spectrometer to decay to zero._Prostatic parenchyma that occupies the posterior and lateral aspects of the prostate gland. The glandular architecture consists of small, round acini amid loosely woven, randomly oriented stroma. The peripheral zone contains large, so-called main glands, whose ducts run posteriorly to open into the urethra. Approximately 70% of the prostate gland lies in the peripheral zone._The final result of a determination of the value, significance, or extent of.","longName":"4382371v1.0:4382373v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"4382371","version":"1","preferredName":"Prostate Imaging-Reporting and Data System","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","longName":"C116385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB2CAE4-93A8-073E-E040-BB89AD437130","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4382373","version":"1","preferredName":"Transverse Spin Relaxation Time Peripheral Zone of the Prostatic Parenchyma Assessment","preferredDefinition":"The time it takes for the net nuclear spin in the plane that is perpendicular to the magnetic field of a spectrometer to decay to zero.:Prostatic parenchyma that occupies the posterior and lateral aspects of the prostate gland. The glandular architecture consists of small, round acini amid loosely woven, randomly oriented stroma. The peripheral zone contains large, so-called main glands, whose ducts run posteriorly to open into the urethra. Approximately 70% of the prostate gland lies in the peripheral zone.:The final result of a determination of the value, significance, or extent of.","longName":"C80364:C33308:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transverse Spin Relaxation Time","conceptCode":"C80364","definition":"The time it takes for the net nuclear spin in the plane that is perpendicular to the magnetic field of a spectrometer to decay to zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Peripheral Zone of the Prostatic Parenchyma","conceptCode":"C33308","definition":"Prostatic parenchyma that occupies the posterior and lateral aspects of the prostate gland. The glandular architecture consists of small, round acini amid loosely woven, randomly oriented stroma. The peripheral zone contains large, so-called main glands, whose ducts run posteriorly to open into the urethra. Approximately 70% of the prostate gland lies in the peripheral zone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB2CAE4-93BB-073E-E040-BB89AD437130","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB2CAE4-93CC-073E-E040-BB89AD437130","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"7/8/14 created for Dr. Pinto C3D PI-RADS Study. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4382592","version":"1","preferredName":"PI-RADS Peripheral Zone Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._Prostatic parenchyma that occupies the posterior and lateral aspects of the prostate gland. The glandular architecture consists of small, round acini amid loosely woven, randomly oriented stroma. The peripheral zone contains large, so-called main glands, whose ducts run posteriorly to open into the urethra. Approximately 70% of the prostate gland lies in the peripheral zone._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"PIRADS_PZ_SCORE","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"5","valueDescription":"Discrete, homogeneous low signal intensity focus with extra-capsular extension/invasive behaviour or mass effect on the capsule (bulging), or broad (>1.5 cm) contact with the surface.","ValueMeaning":{"publicId":"4382593","version":"1","preferredName":"Discrete, homogeneous low signal intensity focus with extra-capsular extension/invasive behaviour or mass effect on the capsule (bulging), or broad (>1.5 cm) contact with the surface.","longName":"4382593","preferredDefinition":"Discrete, homogeneous low signal intensity focus with extra-capsular extension/invasive behaviour or mass effect on the capsule (bulging), or broad (>1.5 cm) contact with the surface.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-0566-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-057F-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"4","valueDescription":"Discrete, homogeneous low signal focus/mass confined to the prostate.","ValueMeaning":{"publicId":"4382594","version":"1","preferredName":"Discrete, homogeneous low signal focus/mass confined to the prostate.","longName":"4382594","preferredDefinition":"Discrete, homogeneous low signal focus/mass confined to the prostate.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-0589-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-05A2-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"3","valueDescription":"Intermediate appearances not in categories a/b or d/e.","ValueMeaning":{"publicId":"4382595","version":"1","preferredName":"Intermediate appearances not in categories a/b or d/e.","longName":"4382595","preferredDefinition":"Intermediate appearances not in categories a/b or d/e.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-05AC-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-05C5-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"2","valueDescription":"Linear, wedge shaped, or geographic areas of lower SI, usually not well demarcated.","ValueMeaning":{"publicId":"4382596","version":"1","preferredName":"Linear, wedge shaped, or geographic areas of lower SI, usually not well demarcated.","longName":"4382596","preferredDefinition":"Linear, wedge shaped, or geographic areas of lower SI, usually not well demarcated.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-05CF-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-05E8-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"1","valueDescription":"Uniform high signal intensity (SI)","ValueMeaning":{"publicId":"4382597","version":"1","preferredName":"Uniform high signal intensity (SI)","longName":"4382597","preferredDefinition":"Uniform high signal intensity (SI)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-05F2-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-060B-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4382591","version":"1","preferredName":"Prostate Imaging-Reporting and Data System Peripheral Zone of the Prostatic Parenchyma Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.:Prostatic parenchyma that occupies the posterior and lateral aspects of the prostate gland. The glandular architecture consists of small, round acini amid loosely woven, randomly oriented stroma. The peripheral zone contains large, so-called main glands, whose ducts run posteriorly to open into the urethra. Approximately 70% of the prostate gland lies in the peripheral zone.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C116385:C33308:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Peripheral Zone of the Prostatic Parenchyma","conceptCode":"C33308","definition":"Prostatic parenchyma that occupies the posterior and lateral aspects of the prostate gland. The glandular architecture consists of small, round acini amid loosely woven, randomly oriented stroma. The peripheral zone contains large, so-called main glands, whose ducts run posteriorly to open into the urethra. Approximately 70% of the prostate gland lies in the peripheral zone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-0540-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-0551-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeDescription":"7/8/14 created for C3D (Dr. Pinto) PI-RADS Protocol 14C0112. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"T2 PI-RADS score for the peri","type":"Preferred Question Text","description":"T2 PI-RADS score for the peripheral zone (PZ)","url":null,"context":"CCR"},{"name":"Short Text","type":"Alternate Question Text","description":"T2 PI-RADS PZ Score","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCAF842-735F-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeDescription":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}